NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-193-2018-0-PCT-02 Improved CRISPR Therapy PCT PCT PCT/US2019/028635 Expired
NIAID E-018-2018-0-TW-03 CHIMERIC VECTORS TW ORD 108114132 Pending
NICHD E-003-2014-0-US-07 CARTILAGE TARGETING AGENTS AND THEIR USE US DIV 16/391,101 10954291 Issued PDF
NHGRI E-243-2012-0-US-18 SYNTHETIC METHYLMALONYL-COA MUTASE TRANSGENE FOR THE TREATMENT OF MUT CLASS METHYLMALONIC ACIDEMIA (MMA) US CON 16/390,917 10894077 Issued PDF
NIA E-205-2006-2-US-27 Preparation Of R,R-fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure US CON 16/390,982 10562843 Issued PDF
NCI E-094-2018-0-PCT-02 METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF PCT PCT PCT/US2019/28513 Expired
NCI E-056-2011-0-US-02 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS US CON 16/389,235 11944673 Issued PDF
NCI E-173-2018-2-US-02 Viral Methods Of T Cell Therapy US CON 16/389,586 Abandoned
NIBIB E-005-2012-2-US-08 ILLUMINATION MICROSCOPY SYSTEMS AND METHODS US CON 16/387,842 10656403 Issued PDF
NIAID E-101-2018-0-US-04 Multi-Specific Antibodies Targeting Human Immunodeficiency Virus And Methods Of Using The Same US National Stage 16/342,962 11149082 Issued PDF
NIAID E-297-2016-2-AU-02 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES AU National Stage 2017332789 Issued
NHLBI E-211-2018-4-US-02 Methods Of Inhibiting Viruses Using Compositions Targeting TSG101-Ubiquitin Interaction US National Stage 16/342,695 Pending
NIAID E-297-2016-2-EP-03 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES EP National Stage 17778443.6 Pending
NCI E-238-2015-0-US-08 MOLECULAR NANOTAGS US National Stage 16/342,345 11536719 Issued PDF
CC E-184-2012-0-US-11 IMAGEABLE EMBOLIC MICROSPHERE US CON 16/381,204 Pending
NLM E-107-2010-2-US-28 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/380,846 11072818 Issued PDF
NCATS E-091-2016-0-US-07 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF MALARIAL PARASITE US National Stage 16/341,000 10988472 Issued PDF
NCI E-276-2016-0-US-05 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS US National Stage 16/340,493 11091509 Issued PDF
NCI E-113-2018-0-PCT-02 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION PCT PCT PCT/US2019/026488 Expired
NCI E-113-2018-0-CN-05 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION CN National Stage 201980039324.7 Pending
NCI E-113-2018-0-EP-06 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION EP National Stage 19723538.5 Pending
NCI E-113-2018-0-JP-07 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION JP National Stage 2020-555199 Pending
NCI E-113-2018-0-AU-03 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION AU National Stage 2019253681 Pending
NCI E-113-2018-0-CA-04 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION CA National Stage 3096305 Pending
NCI E-062-2019-3-NZ-06 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide NZ National Stage 752345 Abandoned
NCI E-062-2019-3-AU-02 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide AU National Stage 2017336547 Abandoned
NCI E-271-2014-0-US-03 A New Class Of Stable Heptamethine Cyanine Fluorophores And Biomedical Applications Thereof US CON 16/374,642 10876003 Issued PDF
NCI E-173-2015-0-US-04 Module For Freezing And Storage Of Frozen Tissue US National Stage 16/338,860 11802821 Issued PDF
NIAID E-279-2016-1-US-03 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE US National Stage 16/338,964 11602559 Issued PDF
NHLBI E-078-2019-0-PCT-02 HELICAL GUIDEWIRES AND RELATED SYSTEMS PCT PCT PCT/US2019/025383 Expired
NIBIB E-225-2014-0-US-05 Resolution Enhancement With Line Scanning Excitation US CON 16/371,641 11106027 Issued PDF
NIAID E-228-2016-1-KR-10 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof KR National Stage 10-2019-7009334 Pending
NCI E-269-2010-0-PT-37 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE PT EP 19166061.2 Issued
NCI E-269-2010-0-ES-31 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE ES EP 19166061.2 Issued
NCI E-269-2010-0-DE-30 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE DE EP 19166061.2 Issued
NCI E-269-2010-0-FR-32 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE FR EP 19166061.2 Issued
NCI E-269-2010-0-IE-34 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE IE EP 19166061.2 Issued
NCI E-269-2010-0-IT-35 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE IT EP 19166061.2 Issued
NCI E-269-2010-0-BE-28 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE BE EP 19166061.2 Issued
NCI E-269-2010-0-AT-27 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE AT EP 19166061.2 Issued
NCI E-269-2010-0-CH-29 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE CH EP 19166061.2 Issued
NCI E-269-2010-0-GB-33 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE GB EP 19166061.2 Issued
NCI E-269-2010-0-NL-36 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE NL EP 19166061.2 Issued
NCI E-269-2010-0-EP-14 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE EP DIV 19166061.2 Issued
NCI E-105-2018-0-PCT-02 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data PCT PCT PCT/US2019/024975 Expired
NIBIB E-005-2012-3-EP-09 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS EP National Stage 18814333.3 Pending
NCI E-062-2019-3-EP-04 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide EP National Stage 17791484.3 Abandoned
NCI E-105-2018-0-CA-04 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data CA National Stage 3095485 Pending
NCI E-105-2018-0-AU-03 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data AU National Stage 2019245402 Pending
NIAID E-228-2016-1-AU-07 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof AU National Stage 2017321883 Issued